Yonesaka, K. (2021). HER2-/HER3-Targeting Antibody—Drug Conjugates for Treating Lung and Colorectal Cancers Resistant to EGFR Inhibitors. Cancers (Basel).
Styl cytowania ChicagoYonesaka, Kimio. "HER2-/HER3-Targeting Antibody—Drug Conjugates for Treating Lung and Colorectal Cancers Resistant to EGFR Inhibitors." Cancers (Basel) 2021.
Styl cytowania MLAYonesaka, Kimio. "HER2-/HER3-Targeting Antibody—Drug Conjugates for Treating Lung and Colorectal Cancers Resistant to EGFR Inhibitors." Cancers (Basel) 2021.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..